Dapagliflozin for heart failure with reduced ejection fraction: early experience of treatment adherence and impact on patient-reported outcomes in EVOLUTION HF, a multinational, observational study
17 May 2025 (08:00 - 12:45)
Organised by: 
About the speaker
Faculty of Medicine University of Porto, Porto (Portugal)
4 More presentations in this session
Associate Professor I. Colluoglu (Izmir, TR)
Doctor S. Doi (Kawasaki, JP)
Doctor Z. Iakobishvili (Tel Aviv, IL)
Access the full session
The Event
Heart Failure 2025
17 May - 20 May 2025
